PRPH Excellent. CEO had been hinting at a special dividend.
What's your take on the whole direct to consumer genomics thing? I know lots of people are into the whole "bio-hacking" type of thing and it seems like the precision medicine thing could catch on. But I wonder if it is truly that useful, or if it's more of a thing were one is convincing oneself of kind of useless stats, "if I eat between 4:30pm and 5:30pm, then people of my genomic type live 2.87% longer."
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.